GLP-1 drug use among women of reproductive age is increasing across the United States, and while experts recommend stopping the drugs before getting pregnant, sometimes unintentional early exposure happens. Now, a new study is offering some reassurance for women in that situation. The study ...
With the U.S. Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the question arises whether other GLP-1 drugs will also soon become available in a pill rather than a needle. This class of medication was ...
Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug Administration (FDA) recently approved a daily pill form of Wegovy, making it the first oral GLP-1 available on the market for weight loss. Manufacturer Novo Nordisk called the ...
